Evidence map›Paper›PMID 33454843›Full record

ArticlePsychopharmacology2021

Cannabinoid type 1 receptors in A2a neurons contribute to cocaine-environment association.

Brandon D Turner, Nicholas K Smith, Kevin M Manz, Betty T Chang, Eric Delpire, Carrie A Grueter, Brad A Grueter

Open access · greenAbstract read
In one paragraph

Article in Psychopharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Brandon D Turner *Vanderbilt Brain Institute, Vanderbilt University, Nashville, TN, 37232, USA.
Nicholas K Smith *Vanderbilt Brain Institute, Vanderbilt University, Nashville, TN, 37232, USA.
Kevin M ManzVanderbilt Brain Institute, Vanderbilt University, Nashville, TN, 37232, USA.
Betty T ChangVanderbilt Brain Institute, Vanderbilt University, Nashville, TN, 37232, USA.
Eric DelpireVanderbilt Brain Institute, Vanderbilt University, Nashville, TN, 37232, USA.
Carrie A GrueterVanderbilt Brain Institute, Vanderbilt University, Nashville, TN, 37232, USA.
Brad A GrueterVanderbilt Brain Institute, Vanderbilt University, Nashville, TN, 37232, USA. brad.grueter@vumc.org.ORCID http://orcid.org/0000-0002-4224-3866
Vanderbilt University · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007347 · NIGMS · VANDERBILT UNIVERSITY · PI WILLIAMS, CHRISTOPHER S. · 1985 to 2023
$26.3M
Overall: Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center at VanderbiltP50HD103537 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Jeffrey L Neul · 2020 to 2026
$10.3M
Medical Scientist Training ProgramT32GM152284 · NIGMS · VANDERBILT UNIVERSITY · PI Christopher S. Williams · 2024 to 2026
$4.8M
Parvalbumin interneurons regulate nucleus accumbens synapses and behaviorR01DA040630 · NIDA · VANDERBILT UNIVERSITY MEDICAL CENTER · PI GRUETER, BRAD ALAN · 2016 to 2025
$4.5M
Gene-Targeted Mouse CoreU01AA013514 · NIAAA · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DELPIRE, ERIC J · 2002 to 2016
$4.3M
Photoperiodic Programming of Monoamine Brain CircuitsR01MH130537 · NIMH · VANDERBILT UNIVERSITY · PI Brad Alan Grueter, DOUGLAS G MCMAHON · 2023 to 2026
$2.6M
Synaptic Mechanisms of Addiction-Related Behaviors in the Nucleus AccumbensR00DA031699 · NIDA · VANDERBILT UNIVERSITY MEDICAL CENTER · PI GRUETER, BRAD ALAN · 2013 to 2015
$743k
NIAAA NIH HHS AA013514NIAAA NIH HHS U01 AA013514NICHD NIH HHS P50 HD103537NIDA NIH HHS DA031699NIDA NIH HHS DA040630NIDA NIH HHS R00 DA031699NIDA NIH HHS R01 DA040630NIGMS NIH HHS T32 GM007347NIGMS NIH HHS T32 GM152284NIMH NIH HHS R01 MH130537
6 · The paper itself

Abstract

rationaleCannabinoid type 1 receptors (CB1Rs) are widely expressed within the brain's reward circuits and are implicated in regulating drug induced behavioral adaptations. Understanding how CB1R signaling in discrete circuits and cell types contributes to drug-related behavior provides further insight into the pathology of substance use disorders. OBJECTIVE AND

methodsWe sought to determine how cell type-specific expression of CB1Rs within striatal circuits contributes to cocaine-induced behavioral plasticity, hypothesizing that CB1R function in distinct striatal neuron populations would differentially impact behavioral outcomes. We crossed conditional Cnr1

resultsBoth knockout lines retained typical locomotor activity at baseline. D1-Cre x Cnr1

conclusionsThis study aids in mapping CB1R-dependent cocaine-induced behavioral adaptations onto distinct striatal neuron subtypes. A reduction of cocaine-induced locomotor activation in the D1- and A2a-Cnr1 knockout mice supports a role for CB1R function in the motor circuit. Furthermore, a lack of preference for cocaine-associated context in A2a-Cnr1 mice suggests that CB1Rs on A2a-neuron inhibitory terminals are necessary for either reward perception, memory consolidation, or recall. These results direct future investigations into CB1R-dependent adaptations underlying the development and persistence of substance use disorders.

Indexed as

EnvironmentAnimalsCocaine-Related DisordersConditioning, OperantCorpus StriatumMaleMiceMice, KnockoutMotor ActivityNeuronsReceptor, Adenosine A2AReceptor, Cannabinoid, CB1RewardADORA2A protein, humanAdora2a protein, mouseReceptor, Adenosine A2AReceptor, Cannabinoid, CB1Cannabinoid receptorCocaineStriatum

Identifiers

PMID33454843
PMCPMC8386588
OpenAlexW3122466240

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.